Biocon acquires Eywa Pharma’s US-based manufacturing facility for $7.7 mn
Biopharma company Biocon’s wholly owned subsidiary, Biocon Generics, has acquired the oral solid dosage manufacturing facility of US-based Eywa
Continue readingThe Number One Finance & Business Blog!
Biopharma company Biocon’s wholly owned subsidiary, Biocon Generics, has acquired the oral solid dosage manufacturing facility of US-based Eywa
Continue reading